Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib.

Lassalle S, Zangari J, Popa A, Ilie M, Hofman V, Long E, Patey M, Tissier F, Belléannée G, Trouette H, Catargi B, Peyrottes I, Sadoul JL, Bordone O, Bonnetaud C, Butori C, Bozec A, Guevara N, Santini J, Hénaoui IS, Lemaire G, Blanck O, Vielh P, Barbry P, Mari B, Brest P, Hofman P.

Oncotarget. 2016 May 24;7(21):30461-78. doi: 10.18632/oncotarget.8458.

2.

Knockout of Vdac1 activates hypoxia-inducible factor through reactive oxygen species generation and induces tumor growth by promoting metabolic reprogramming and inflammation.

Brahimi-Horn MC, Giuliano S, Saland E, Lacas-Gervais S, Sheiko T, Pelletier J, Bourget I, Bost F, Féral C, Boulter E, Tauc M, Ivan M, Garmy-Susini B, Popa A, Mari B, Sarry JE, Craigen WJ, Pouysségur J, Mazure NM.

Cancer Metab. 2015 Aug 26;3:8. doi: 10.1186/s40170-015-0133-5.

3.

The small heat shock protein B8 (HSPB8) confers resistance to bortezomib by promoting autophagic removal of misfolded proteins in multiple myeloma cells.

Hamouda MA, Belhacene N, Puissant A, Colosetti P, Robert G, Jacquel A, Mari B, Auberger P, Luciano F.

Oncotarget. 2014 Aug 15;5(15):6252-66.

4.

Phenotypic and genotypic characterization of azacitidine-sensitive and resistant SKM1 myeloid cell lines.

Cluzeau T, Dubois A, Jacquel A, Luciano F, Renneville A, Preudhomme C, Karsenti JM, Mounier N, Rohrlich P, Raynaud S, Mari B, Robert G, Auberger P.

Oncotarget. 2014 Jun 30;5(12):4384-91.

5.

⁹⁹mTcO₄--, auger-mediated thyroid stunning: dosimetric requirements and associated molecular events.

Cambien B, Franken PR, Lamit A, Mauxion T, Richard-Fiardo P, Guglielmi J, Crescence L, Mari B, Pourcher T, Darcourt J, Bardiès M, Vassaux G.

PLoS One. 2014 Mar 24;9(3):e92729. doi: 10.1371/journal.pone.0092729.

6.

Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties.

Bertero T, Bourget-Ponzio I, Puissant A, Loubat A, Mari B, Meneguzzi G, Auberger P, Barbry P, Ponzio G, Rezzonico R.

Cell Cycle. 2013 Jul 15;12(14):2183-93. doi: 10.4161/cc.25330.

7.

Recurrent intraventricular thrombus six months after ST-elevation myocardial infarction in a diabetic man: a case report.

Lacalzada J, Marí B, Izquierdo MM, Sánchez-Grande A, de la Rosa A, Laynez I.

BMC Res Notes. 2013 Sep 2;6:348. doi: 10.1186/1756-0500-6-348.

8.

Transient global amnesia: linked to a systemic disorder of amino acid catabolism?

Sancesario G, Esposito Z, Mozzi AF, Sancesario GM, Martorana A, Giordano A, Sorge R, Mari B, Spalletta G, Marciani MG, Bernardini S.

J Neurol. 2013 May;260(5):1429-32. doi: 10.1007/s00415-013-6927-x. No abstract available.

9.

A novel role for the RNA-binding protein FXR1P in myoblasts cell-cycle progression by modulating p21/Cdkn1a/Cip1/Waf1 mRNA stability.

Davidovic L, Durand N, Khalfallah O, Tabet R, Barbry P, Mari B, Sacconi S, Moine H, Bardoni B.

PLoS Genet. 2013 Mar;9(3):e1003367. doi: 10.1371/journal.pgen.1003367.

10.

MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines.

Grosso S, Doyen J, Parks SK, Bertero T, Paye A, Cardinaud B, Gounon P, Lacas-Gervais S, Noël A, Pouysségur J, Barbry P, Mazure NM, Mari B.

Cell Death Dis. 2013 Mar 14;4:e544. doi: 10.1038/cddis.2013.71.

11.

miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1.

Lino Cardenas CL, Henaoui IS, Courcot E, Roderburg C, Cauffiez C, Aubert S, Copin MC, Wallaert B, Glowacki F, Dewaeles E, Milosevic J, Maurizio J, Tedrow J, Marcet B, Lo-Guidice JM, Kaminski N, Barbry P, Luedde T, Perrais M, Mari B, Pottier N.

PLoS Genet. 2013;9(2):e1003291. doi: 10.1371/journal.pgen.1003291.

12.

CDC25A targeting by miR-483-3p decreases CCND-CDK4/6 assembly and contributes to cell cycle arrest.

Bertero T, Gastaldi C, Bourget-Ponzio I, Mari B, Meneguzzi G, Barbry P, Ponzio G, Rezzonico R.

Cell Death Differ. 2013 Jun;20(6):800-11. doi: 10.1038/cdd.2013.5.

13.

"Seed-Milarity" confers to hsa-miR-210 and hsa-miR-147b similar functional activity.

Bertero T, Grosso S, Robbe-Sermesant K, Lebrigand K, Hénaoui IS, Puisségur MP, Fourre S, Zaragosi LE, Mazure NM, Ponzio G, Cardinaud B, Barbry P, Rezzonico R, Mari B.

PLoS One. 2012;7(9):e44919. doi: 10.1371/journal.pone.0044919.

14.

On the Pro-Metastatic Stress Response to Cancer Therapies: Evidence for a Positive Co-Operation between TIMP-1, HIF-1α, and miR-210.

Cui H, Grosso S, Schelter F, Mari B, Krüger A.

Front Pharmacol. 2012 Jul 12;3:134. doi: 10.3389/fphar.2012.00134.

15.

Spt6 levels are modulated by PAAF1 and proteasome to regulate the HIV-1 LTR.

Nakamura M, Basavarajaiah P, Rousset E, Beraud C, Latreille D, Henaoui IS, Lassot I, Mari B, Kiernan R.

Retrovirology. 2012 Feb 8;9:13. doi: 10.1186/1742-4690-9-13.

16.

Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis.

Zaragosi LE, Wdziekonski B, Brigand KL, Villageois P, Mari B, Waldmann R, Dani C, Barbry P.

Genome Biol. 2011 Jul 18;12(7):R64. doi: 10.1186/gb-2011-12-7-r64.

17.

Nanostructured hybrid ZnO thin films for energy conversion.

Moya M, Samantilleke AP, Mollar M, Marí B.

Nanoscale Res Lett. 2011 May 16;6(1):384. doi: 10.1186/1556-276X-6-384.

18.

MiRonTop: mining microRNAs targets across large scale gene expression studies.

Le Brigand K, Robbe-Sermesant K, Mari B, Barbry P.

Bioinformatics. 2010 Dec 15;26(24):3131-2. doi: 10.1093/bioinformatics/btq589.

19.

miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity.

Puisségur MP, Mazure NM, Bertero T, Pradelli L, Grosso S, Robbe-Sermesant K, Maurin T, Lebrigand K, Cardinaud B, Hofman V, Fourre S, Magnone V, Ricci JE, Pouysségur J, Gounon P, Hofman P, Barbry P, Mari B.

Cell Death Differ. 2011 Mar;18(3):465-78. doi: 10.1038/cdd.2010.119.

20.

Innovative approach for transcriptomic analysis of obligate intracellular pathogen: selective capture of transcribed sequences of Ehrlichia ruminantium.

Emboulé L, Daigle F, Meyer DF, Mari B, Pinarello V, Sheikboudou C, Magnone V, Frutos R, Viari A, Barbry P, Martinez D, Lefrançois T, Vachiéry N.

BMC Mol Biol. 2009 Dec 24;10:111. doi: 10.1186/1471-2199-10-111.

Items per page

Supplemental Content

Loading ...
Support Center